Home LiteratureArticle Details
PMID: 17360464 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Invariant NKT cells sustain specific B cell responses and memory.

Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M, Maione D, Volpini G, Finco O, Nuti S, Tavarini S, Dellabona P, Rappuoli R, Casorati G, Abrignani S

Abstract

Invariant natural killer T (iNKT) cells are innate-like lymphocytes recognizing CD1d-restricted glycolipid antigens, such as alpha-galactosylceramide (alphaGC). We assessed whether iNKT cells help B lymphocyte responses and found that mice immunized with proteins and alphaGC develop antibody titers 1-2 logs higher than those induced by proteins alone. Activation of iNKT cells enhances protection against infections such as influenza and elicits higher frequencies of memory B cells and higher antibody responses to booster immunizations. Protein vaccination with alphaGC, but not with conventional adjuvants, elicits IgG responses in mice lacking MHC class II molecules, demonstrating that iNKT cells can substitute for CD4(+) T cell help to B cells. Interestingly, the decay of circulating antibodies is faster in mice lacking iNKT cells. These findings point to a homeostatic role for iNKT cells on critical features of the antibody response such as immunity and B cell memory.

MeSH Terms
Animals Antigens, CD1/metabolism Antigens, CD1d B-Lymphocytes/metabolism,virology CD4-Positive T-Lymphocytes/metabolism Galactosylceramides/metabolism Immune System Immunologic Memory Killer Cells, Natural/metabolism,virology Mice Mice, Inbred BALB C Mice, Inbred C3H Mice, Inbred C57BL Mice, Transgenic Orthomyxoviridae Infections/immunology Time Factors
Chemicals
Antigens, CD1 Antigens, CD1d Galactosylceramides alpha-galactosylceramide
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Galli Grazia
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Pittoni Paola
Tonti Elena
Malzone Carmine
Uematsu Yasushi
Tortoli Marco
Maione Domenico
Volpini Gianfranco
Finco Oretta
Nuti Sandra
Tavarini Simona
Dellabona Paolo
Rappuoli Rino
Casorati Giulia
Abrignani Sergio
References (49)
49 references, click to expand
  1. Activated human NK cells can stimulate resting B cells to secrete immunoglobulin.
    J Immunol. 1995 Jun 1;154(11):5656-64 PMID: 7751617
  2. Use of CpG oligodeoxynucleotides as immune adjuvants.
    Immunol Rev. 2004 Jun;199:201-16 PMID: 15233736
  3. Clonal selection and learning in the antibody system.
    Nature. 1996 Jun 27;381(6585):751-8 PMID: 8657279
  4. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.
    Vaccine. 1996 Apr;14(6):478-84 PMID: 8782343
  5. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells.
    Science. 1997 Feb 14;275(5302):977-9 PMID: 9020080
  6. Mouse CD1-specific NK1 T cells: development, specificity, and function.
    Annu Rev Immunol. 1997;15:535-62 PMID: 9143699
  7. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.
    J Exp Med. 1997 Jul 7;186(1):109-20 PMID: 9207002
  8. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
    Science. 1997 Nov 28;278(5343):1623-6 PMID: 9374462
  9. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Science. 1997 Nov 28;278(5343):1626-9 PMID: 9374463
  10. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
    J Exp Med. 1998 Oct 19;188(8):1521-8 PMID: 9782129
  11. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Annu Rev Immunol. 1999;17:297-329 PMID: 10358761
  12. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    J Immunol. 1999 Sep 1;163(5):2373-7 PMID: 10452969
  13. Lysosomal glycosphingolipid recognition by NKT cells.
    Science. 2004 Dec 3;306(5702):1786-9 PMID: 15539565
  14. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
    Nat Rev Immunol. 2005 Jan;5(1):31-42 PMID: 15630427
  15. Aluminium compounds for use in vaccines.
    Immunol Cell Biol. 2004 Oct;82(5):497-505 PMID: 15479435
  16. Mice lacking MHC class II molecules.
    Cell. 1991 Sep 6;66(5):1051-66 PMID: 1909605
  17. Generation and analysis of interleukin-4 deficient mice.
    Science. 1991 Nov 1;254(5032):707-10 PMID: 1948049
  18. Freund's complete adjuvant: an effective but disagreeable formula.
    Res Immunol. 1992 Jun;143(5):478-83; discussion 572 PMID: 1439126
  19. Activation of B lymphocytes by NK cells.
    Int Immunol. 1992 Dec;4(12):1373-80 PMID: 1286061
  20. Immune response in mice that lack the interferon-gamma receptor.
    Science. 1993 Mar 19;259(5102):1742-5 PMID: 8456301
  21. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
    J Exp Med. 1994 Sep 1;180(3):1097-106 PMID: 7520467
  22. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.
    J Exp Med. 1994 Sep 1;180(3):1171-6 PMID: 8064234
  23. Maintenance of serum antibody levels.
    Annu Rev Immunol. 2005;23:367-86 PMID: 15771575
  24. Recognition of bacterial glycosphingolipids by natural killer T cells.
    Nature. 2005 Mar 24;434(7032):520-5 PMID: 15791257
  25. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
    Nature. 2005 Mar 24;434(7032):525-9 PMID: 15791258
  26. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.
    J Immunol. 2005 Sep 1;175(5):3092-101 PMID: 16116198
  27. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    J Immunol. 2005 Sep 1;175(5):3309-17 PMID: 16116223
  28. Glycolipid antigen induces long-term natural killer T cell anergy in mice.
    J Clin Invest. 2005 Sep;115(9):2572-83 PMID: 16138194
  29. Control of B-cell responses by Toll-like receptors.
    Nature. 2005 Nov 17;438(7066):364-8 PMID: 16292312
  30. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
    Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3972-7 PMID: 16537470
  31. Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
    Eur J Immunol. 2006 Apr;36(4):810-6 PMID: 16541472
  32. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
    Nat Immunol. 2006 Sep;7(9):978-86 PMID: 16921381
  33. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Immunology. 2006 Sep;119(1):116-25 PMID: 16792697
  34. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
    Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8461-6 PMID: 10900007
  35. NKT cells - conductors of tumor immunity?
    Curr Opin Immunol. 2002 Apr;14(2):165-71 PMID: 11869887
  36. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.
    J Exp Med. 2002 Mar 4;195(5):617-24 PMID: 11877484
  37. Maintenance of serological memory by polyclonal activation of human memory B cells.
    Science. 2002 Dec 13;298(5601):2199-202 PMID: 12481138
  38. Interleukin-12 and the regulation of innate resistance and adaptive immunity.
    Nat Rev Immunol. 2003 Feb;3(2):133-46 PMID: 12563297
  39. The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
    Annu Rev Immunol. 2003;21:483-513 PMID: 12543936
  40. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    J Exp Med. 2003 Apr 21;197(8):1051-7 PMID: 12695492
  41. Regulation of dendritic cell function through Toll-like receptors.
    Curr Mol Med. 2003 Jun;3(4):373-85 PMID: 12776992
  42. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
    J Exp Med. 2003 Jul 21;198(2):267-79 PMID: 12874260
  43. MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
    Expert Rev Vaccines. 2003 Apr;2(2):197-203 PMID: 12899571
  44. Role of CD1d-restricted NKT cells in microbial immunity.
    Infect Immun. 2003 Oct;71(10):5447-55 PMID: 14500461
  45. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.
    J Exp Med. 2003 Oct 6;198(7):1069-76 PMID: 14530376
  46. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    J Immunol. 2003 Nov 15;171(10):5140-7 PMID: 14607913
  47. CD1: antigen presentation and T cell function.
    Annu Rev Immunol. 2004;22:817-90 PMID: 15032598
  48. NKT cells: what's in a name?
    Nat Rev Immunol. 2004 Mar;4(3):231-7 PMID: 15039760
  49. CD1 recognition by mouse NK1+ T lymphocytes.
    Science. 1995 May 12;268(5212):863-5 PMID: 7538697
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2007-03-06
Epub
2007-00-27
Pages
3984-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1805488
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com